KACEYANNE CERANKOWSKI: Open Payments
NPI 1811531767 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,244 in 59 payments from 20 companies in 2025. Trend: 2023 $206 · 2024 $92 · 2025 $1,244
Food & beverage: $1,244
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 9 | $275 |
| ABBVIE INC. | 9 | $158 |
| Verona Pharma, Inc. | 6 | $146 |
| Novo Nordisk Inc | 6 | $95 |
| Lilly USA, LLC | 5 | $83 |
| Lundbeck LLC | 3 | $66 |
| GlaxoSmithKline, LLC. | 2 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Exact Sciences Corporation | 2 | $41 |
Products named: REXULTI, Ohtuvayre, VRAYLAR, MOUNJARO, TRELEGY ELLIPTA, TRINTELLIX, CAPLYTA, The Cologuard Plus Collection Kit.
Industry payments across NJ — which companies pay providers there.
